Antimicrobial resistance in eight US hospitals along the US–Mexico border, 2000–2006

SUMMARY Antimicrobial resistance (AR) is a growing problem worldwide and international travel, cross-border migration, and antimicrobial use may contribute to the introduction or emergence of AR. We examined AR rates and trends along the US–Mexico border by analysing microbiology data from eight US hospitals in three states bordering Mexico. Microbiology data were ascertained for the years 2000–2006 and for select healthcare and community pathogens including, three Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae) and three Gram-positive (Staphylococcus aureus, Enterococcus, Streptococcus pneumoniae) pathogens and 10 antimicrobial–pathogen combinations. Resistance was highest in S. aureus (oxacillin resistance 45·7%), P. aeruginosa (quinolone resistance 22·3%), and E. coli (quinolone resistance 15·6%); six (60%) of the 10 antimicrobial–pathogen combinations studied had a significantly increasing trend in resistance over the study period. Potential contributing factors in the hospital and community such as infection control practices and antimicrobial use (prescription and non-prescription) should be explored further in the US–Mexico border region.

[1]  V. Wirtz,et al.  Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation , 2012, BMC Public Health.

[2]  M. Landrum,et al.  Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. , 2012, JAMA.

[3]  J. Karlowsky,et al.  In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010 , 2012, Antimicrobial Agents and Chemotherapy.

[4]  D. Paterson,et al.  Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  C. Whitney,et al.  Shifting genetic structure of invasive serotype 19A pneumococci in the United States. , 2011, The Journal of infectious diseases.

[6]  P. Gubbins,et al.  Population Mobility, Globalization, and Antimicrobial Drug Resistance , 2009, Emerging infectious diseases.

[7]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[8]  T. Byrd,et al.  Cross-border utilization of health care services by United States residents living near the Mexican border. , 2009, Revista panamericana de salud publica = Pan American journal of public health.

[9]  J. Jernigan,et al.  Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. , 2009, JAMA.

[10]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[11]  T. Mackenzie,et al.  Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. , 2008, The American journal of medicine.

[12]  J. Maselli,et al.  National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. , 2008, Archives of internal medicine.

[13]  J. Rizzo,et al.  Health care access, use of services, and experiences among undocumented Mexicans and other Latinos. , 2007, Archives of internal medicine.

[14]  R. Clark,et al.  A survey of the use of foreign-purchased medications in a border community emergency department patient population. , 2007, The Journal of emergency medicine.

[15]  C. Gagliotti,et al.  Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  S. Cosgrove.  Evidence that prevention makes cents: Costs of catheter-associated bloodstream infections in the intensive care unit. , 2006, Critical care medicine.

[17]  W. Schaffner,et al.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.

[18]  H. Welch,et al.  Current antibiotic therapy for isolated urinary tract infections in women. , 2006, Archives of internal medicine.

[19]  R. Gaynes,et al.  Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  James G. Johnson,et al.  Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Gustafson,et al.  Survey of Methicillin-Resistant Staphylococcus aureus Strains from Two Hospitals in El Paso, Texas , 2005, Journal of Clinical Microbiology.

[22]  R. Lynfield,et al.  Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.

[23]  S. Segal-Maurer,et al.  Increased Mortality Associated With a Clonal Outbreak of Ceftazidime-Resistant Klebsiella pneumoniae: A Case–Control Study , 2005, Infection Control & Hospital Epidemiology.

[24]  I. Peláez-Ballestas,et al.  Use of antibiotics in upper respiratory infections on patients under 16 years old in private ambulatory medicine. , 2003, Salud publica de Mexico.

[25]  J. A. Ortiz,et al.  The U.S.-Mexico Border Infectious Disease Surveillance Project: Establishing Binational Border Surveillance , 2003, Emerging infectious diseases.

[26]  T. Doyle,et al.  Infectious disease morbidity in the US region bordering Mexico, 1990-1998. , 2000, The Journal of infectious diseases.

[27]  J F Steiner,et al.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. , 1998, JAMA.

[28]  D. Sugerman,et al.  Public health surveillance using emergency medical service logs - U.S.--Mexico land border, El Paso, Texas, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[29]  S. Antony,et al.  Study of methicillin-resistant Staphylococcus aureus on the U.S./Mexico border. , 2009, Travel medicine and infectious disease.

[30]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[31]  Marcia M Ward,et al.  Antimicrobial resistance trends and outbreak frequency in United States hospitals. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.